AYTU BIOPHARMA, INC — Director's Dealing 2016

May 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-05-06

Reporting Person: DOCKERY CARL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-06	Common Stock	P	5000000	$0.40	Acquired	5047591	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option Grant	$0.56	2026-04-10	Common Stock (100000)	100000	Direct